A carregar...
Clinical benefit derived from decitabine therapy for advanced phases of myeloproliferative neoplasms
Treatment options are limited for patients with advanced forms of myeloproliferative neoplasms (MPN), including blast phase disease (MPN-BP). Decitabine has frequently been employed but its efficacy and safety profile are not well described in this population. We retrospectively reviewed 42 patients...
Na minha lista:
| Publicado no: | Acta Haematol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7773003/ https://ncbi.nlm.nih.gov/pubmed/32160610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506146 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|